Worth reading
31Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
6361700
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
Shares delivered during the month: 6,361,700 (6,361,700 new shares and 0 transferred treasury shares)
発行済株式総数
Exercise ratio subject to exercise restrictions: 1.60% (6,361,700 shares delivered for all series combined / 398,835,550 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price during the month: ¥33–¥36. Details of the adjustment clauses: Not disclosed in this document.
Number of Stock Acquisition Rights
Total issued: 796,337 (7.99% of the total issued represented by exercises during the month); unexercised at 31 August 2026: 796,337; unexercised at the end of September 2026: 732,720
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Transactions.
Most recent equity financing
Issued on 31 August 2026: Series 47 Stock Acquisition Rights with Exercise Price Adjustment Clauses; total issued: 796,337 (as stated in this document)
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | Shares delivered during the month: 6,361,700 (6,361,700 new shares and 0 transferred treasury shares) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 1.60% (6,361,700 shares delivered for all series combined / 398,835,550 listed shares as of the payment date for the issuance) |
| Total number of issued shares | 398,835,550 shares (as of the end of the month preceding the subject month, including 230 treasury shares) → Not disclosed |
| Exercise price | Exercise price during the month: ¥33–¥36. Details of the adjustment clauses: Not disclosed in this document. |
| Number of Stock Acquisition Rights | Total issued: 796,337 (7.99% of the total issued represented by exercises during the month); unexercised at 31 August 2026: 796,337; unexercised at the end of September 2026: 732,720 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Transactions. |
| Most recent equity financing | Issued on 31 August 2026: Series 47 Stock Acquisition Rights with Exercise Price Adjustment Clauses; total issued: 796,337 (as stated in this document) |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the Series 47 Stock Acquisition Rights with Exercise Price Adjustment Clauses for September 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.